From Treatment to Investment: Considering Opportunities Surrounding the GLP-1 Biopharmaceutical Revolution By Trevor Isham, CFP®, Partner, Senior Wealth Manager and Jeff Jones, CFA®, CPA, Partner, Portfolio Manager March 21, 2024